Lalji Superspeciality Hospital & Reserch Centre Gorakhpur Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
as on 23-12-2024
- Paid Up Capital ₹ 50.60 Cr
as on 23-12-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit 87.65%
(FY 2020)
- Ebitda 91.66%
(FY 2020)
- Net Worth 13605.31%
(FY 2020)
- Total Assets 18.35%
(FY 2020)
About Lalji Superspeciality Hospital & Reserch Centre Gorakhpur
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 50.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shiv Prajapati and Sriram Prajapti serve as directors at the Company.
- CIN/LLPIN
U85100DL2015PTC286997
- Company No.
286997
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Nov 2015
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Lalji Superspeciality Hospital & Reserch Centre Gorakhpur?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shiv Prajapati  | Director | 02-Nov-2015 | Current |
| Sriram Prajapti | Director | 20-Jan-2021 | Current |
Financial Performance of Lalji Superspeciality Hospital & Reserch Centre Gorakhpur.
Lalji Superspeciality Hospital & Reserch Centre Gorakhpur Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 87.65% increase in profit. The company's net worth Soared by an impressive increase of 13605.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lalji Superspeciality Hospital & Reserch Centre Gorakhpur?
In 2019, Lalji Superspeciality Hospital & Reserch Centre Gorakhpur had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Vision Real Estate Developers Private LimitedActive 12 years 4 months
Shiv Prajapati is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lalji Superspeciality Hospital & Reserch Centre Gorakhpur?
Unlock and access historical data on people associated with Lalji Superspeciality Hospital & Reserch Centre Gorakhpur, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lalji Superspeciality Hospital & Reserch Centre Gorakhpur, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lalji Superspeciality Hospital & Reserch Centre Gorakhpur's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
